Evidence map›Paper›PMID 7760819›Full record

ArticleMolecular and cellular biology1995

A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways.

A J Kudla, M L John, D F Bowen-Pope, B Rainish, B B Olwin

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

A J KudlaDepartment of Biochemistry, Purdue University, West Lafayette, Indiana 47907, USA.
M L John
D F Bowen-Pope
B Rainish
B B Olwin
Purdue University West Lafayette · USUniversity of Illinois Urbana-Champaign · USUniversity of Wisconsin–Madison · US

Funding

MYOGENIC GRWOTH AND DIFFERENTIATIONR01AR039467 · NIAMS · UNIVERSITY OF COLORADO AT BOULDER · PI OLWIN, BRADLEY B · 1994 to 2008
$2.8M
REGULATION OF PDGF RECEPTORSR01GM035501 · NIGMS · UNIVERSITY OF WASHINGTON · PI BOWEN-POPE, DANIEL F · 1985 to 1994
–
ANALYSIS OF MYOGENIC GROWTH AND DIFFERENTIATIONR29AR039467 · NIAMS · UNIVERSITY OF WISCONSIN MADISON · PI OLWIN, BRADLEY B · 1988 to 1992
–
NIAMS NIH HHS AR39467NIGMS NIH HHS GM35501
6 · The paper itself

Abstract

The distinct effects of cytokines on cellular growth and differentiation suggest that specific signaling pathways mediate these diverse biological activities. Fibroblast growth factors (FGFs) are well-established inhibitors of skeletal muscle differentiation and may operate via activation of specific signaling pathways distinct from recently identified mitogen signaling pathways. We examined whether platelet-derived growth factor (PDGF)-activated signaling pathways are sufficient to mediate FGF-dependent repression of myogenesis by introducing the PDGF beta receptor into a mouse skeletal muscle cell line. Addition of PDGF-BB to cells expressing the PDGF beta receptor activated the PDGF beta receptor tyrosine kinase, stimulated mitogen-activated protein (MAP) kinase, and increased the steady-state levels of junB and c-fos mRNAs. Despite the activation of these intracellular signaling molecules, PDGF beta receptor activation elicited no detectable effect on cell proliferation or differentiation. In contrast to PDGF-BB, addition of FGF-2 to myoblasts activated signaling pathways that resulted in DNA synthesis and repression of differentiation. Because of the low number of endogenous FGF receptors expressed, FGF-stimulated signaling events, including tyrosine phosphorylation and activation of MAP kinase, could be detected only in cells expressing higher levels of a transfected FGF receptor cDNA. As the PDGF beta receptor- and FGF receptor-stimulated signaling pathways yield different biological responses in these skeletal muscle cells, we hypothesize that FGF-mediated repression of skeletal muscle differentiation activates signaling pathways distinct from those activated by the PDGF beta receptor. Activation of PDGF beta receptor tyrosine kinase activity, stimulation of MAP kinase, and upregulation of immediate-early gene expression are not sufficient to repress skeletal muscle differentiation.

Indexed as

Muscle DevelopmentAnimalsCell DifferentiationCell DivisionCell LineFibroblast Growth FactorsGene Expression RegulationMiceMuscle, SkeletalPlatelet-Derived Growth FactorReceptor, Platelet-Derived Growth Factor betaReceptors, Platelet-Derived Growth FactorSecond Messenger SystemsSignal TransductionFibroblast Growth FactorsPlatelet-Derived Growth FactorReceptor, Platelet-Derived Growth Factor betaReceptors, Platelet-Derived Growth Factor

Identifiers

PMID7760819
PMCPMC230556
OpenAlexW2161195378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.